Absolute Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287K Buy
+1,098
New +$281K 0.07% 145
2026
Q1
– Sell
-1,158
Closed -$265K – 147
2025
Q4
$265K Buy
1,158
+181
+19% +$41.2K 0.1% 113
2025
Q3
$226K Buy
+977
New +$199K 0.1% 114
2022
Q4
– Sell
-136
Closed -$18.9K – 74
2022
Q3
$18.9K Buy
+136
New +$19.5K 0.02% 140
2022
Q1
– Sell
-56
Closed -$7.58K – 56
2021
Q4
$7.58K Buy
+56
New +$6.62K 0.01% 209

Other funds holding ABBV

Absolute Capital Management's ABBV Position: Q3 2026 in Review

Absolute Capital Management opened a new position in AbbVie (ABBV) in Q3 2026: 1,098 shares worth $287K. The stake represents 0.07% of the portfolio and ranks #145 among its holdings. This is a return to the name: Absolute Capital Management previously reported a position in ABBV as recently as Q4 2025.

Absolute Capital Management first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Absolute Capital Management held 1,098 shares of AbbVie worth $287K as of Q3 2026.
  • AbbVie was a new Absolute Capital Management position in Q3 2026.
  • AbbVie made up 0.07% of Absolute Capital Management's portfolio in Q3 2026, its #145 holding.
  • Absolute Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Absolute Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.